# Study to Assess Safety, Tolerability and Pharmacokinetics of Treamid in Healthy Volunteers

> **NCT04428593** · PHASE1 · COMPLETED · sponsor: **PHARMENTERPRISES LLC** · enrollment: 20 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** Treamid 5 mg
- **DRUG:** Treamid 15 mg
- **DRUG:** Treamid 50 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04428593
- **Lead sponsor:** PHARMENTERPRISES LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-25
- **Primary completion:** 2016-11-21
- **Final completion:** 2016-11-21
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04428593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04428593, "Study to Assess Safety, Tolerability and Pharmacokinetics of Treamid in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04428593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*